Related Experiment Video
Updated: Feb 16, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
Published on: March 30, 2022
Interferon regulatory factor 5 (IRF5) regulates the expression of matrix metalloproteinase-3 (MMP-3) in human
Lin Guo1, Ruihu Hao2, Fengde Tian2
1Department of Orthopedics, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Abstract:
Matrix metalloproteinase-3 (MMP-3) plays a pivotal role in the destruction of articular cartilage in osteoarthritis (OA). The regulation of gene expression of MMP-3 is complicated. Interferon regulatory factor 5 (IRF5) is a member of the interferon regulatory factor family of transcription factors. Little information regarding the biological function of IRF5 on chondrocytes and the pathogenesis of OA has been reported. In the current study, for the first time, we report that IRF5 is expressed in human primary chondrocytes and human chondrosarcoma cell line SW1353 cells. In addition, IRF5 is upregulated in response to TNF-α treatment in a dose dependent manner. Interestingly, IRF5 is significantly higher in chondrocytes from OA patients compared to those from normal subjects. Notably, IRF5 mediates TNF-α- induced expression of MMP-3 in chondrocytes. Overexpression of IRF5 promotes the expression of MMP-3, however, knockdown of IRF5 reduces the expression of MMP-3. Mechanistically, IRF5 is able to enhance the transcription of MMP-3 by binding to its promoter. Also, we found that NF-κB was involved in the effects of IRF-5 on MMP-3 expression. These findings suggest that IRF5 might be a novel pharmacological target for the treatment of OA and RA.
Insights
Interferon regulatory factor 5 (IRF5) promotes matrix metalloproteinase-3 (MMP-3) expression in osteoarthritis. IRF5 may be a new therapeutic target for osteoarthritis and rheumatoid arthritis.
Area of Science:
- Molecular biology
- Immunology
- Rheumatology
Background:
- Matrix metalloproteinase-3 (MMP-3) is key in osteoarthritis (OA) cartilage destruction.
- Regulation of MMP-3 gene expression is complex.
- The role of Interferon regulatory factor 5 (IRF5) in chondrocytes and OA is largely unknown.
Purpose of the Study:
- To investigate the role of IRF5 in OA pathogenesis.
- To determine if IRF5 regulates MMP-3 expression in chondrocytes.
Main Methods:
- IRF5 expression analysis in human chondrocytes and cell lines.
- Investigated IRF5 regulation by TNF-α.
- Assessed IRF5's effect on MMP-3 expression via overexpression and knockdown.
- Analyzed IRF5 binding to the MMP-3 promoter.
- Examined the involvement of NF-κB.
Main Results:
- IRF5 is expressed in human chondrocytes and upregulated by TNF-α.
- IRF5 levels are higher in OA chondrocytes compared to normal.
- IRF5 directly enhances MMP-3 transcription by binding to its promoter.
- IRF5 mediates TNF-α-induced MMP-3 expression, involving NF-κB.
Conclusions:
- IRF5 plays a significant role in MMP-3 expression in chondrocytes.
- IRF5 is a potential therapeutic target for osteoarthritis (OA) and rheumatoid arthritis (RA).
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Cis-regulatory Sequences
Master Transcription Regulators
Transcription Factors

